These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 13706131)

  • 1. [Antigenic, immunogenic and toxic properties of typhoid bacteria resistant to levomycetin].
    GNETNEV AM
    Antibiotiki; 1961 Jun; 6():517-21. PubMed ID: 13706131
    [No Abstract]   [Full Text] [Related]  

  • 2. Chloramphenicol-resistant strains of Salmonella typhosa. I. Induction of morphological, cultural, and antigenic changes.
    WEINER LM; SWANSON RE
    J Bacteriol; 1960 Jun; 79(6):863-8. PubMed ID: 13843575
    [No Abstract]   [Full Text] [Related]  

  • 3. [Catalase and peroxidase activity of typhoid bacteria sensitive and resistant to levomycetin].
    SHUB GM; SHENDEROV BA
    Antibiotiki; 1963 Jan; 8():69-71. PubMed ID: 13988743
    [No Abstract]   [Full Text] [Related]  

  • 4. Ofloxacin--a possible breakthrough in the treatment of typhoid fever caused by chloramphenicol resistant Salmonella typhi.
    Hannan A; Ahmed SA; Akhtar MA; Anwar CM; Mahmood S; Kaleem M; Iqbal M
    J Chemother; 1989 Jul; 1(4 Suppl):383-5. PubMed ID: 16312451
    [No Abstract]   [Full Text] [Related]  

  • 5. Re-emerging chloramphenicol sensitivity and emerging low level ciprofloxacin resistance among Salmonella enterica serotype typhi isolates in North India.
    Gupta V; Kaur J; Kaistha N
    Trop Doct; 2009 Jan; 39(1):28-30. PubMed ID: 19211419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CATALASE AND PEROXIDASE ACTIVITY OF TYPHOID BACTERIA SENSITIVE AND RESISTANT TO CHLORAMPHENICOL.
    SHUB GM; SHENDEROV BA
    Fed Proc Transl Suppl; 1963; 22():795-6. PubMed ID: 14060255
    [No Abstract]   [Full Text] [Related]  

  • 7. [STUDY OF VI ANTIGEN OF LEVOMYCETIN-RESISTANT SALMONELLA TYPHOSA BACTERIA].
    GNETNEV AM
    Zh Mikrobiol Epidemiol Immunobiol; 1964 Jan; 41():14-7. PubMed ID: 14182384
    [No Abstract]   [Full Text] [Related]  

  • 8. Emergence of multidrug-resistant Salmonella enterica serovar typhi in Korea.
    Lee K; Yong D; Yum JH; Lim YS; Kim HS; Lee BK; Chong Y
    Antimicrob Agents Chemother; 2004 Nov; 48(11):4130-5. PubMed ID: 15504831
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiology of typhoid and paratyphoid fever in Kathmandu: two years study and trends of antimicrobial resistance.
    Malla S; Kansakar P; Serichantalergs O; Rahman M; Basnet S
    JNMA J Nepal Med Assoc; 2005; 44(157):18-22. PubMed ID: 16082406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing trends in antimicrobial resistance of Salmonella enterica serovar typhi and salmonella enterica serovar paratyphi A in Chennai.
    Krishnan P; Stalin M; Balasubramanian S
    Indian J Pathol Microbiol; 2009; 52(4):505-8. PubMed ID: 19805957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relation to immunogenesis to variation of antigenic and immunogenic properties of the microbe during levomycetin therapy of experimental paratyphoid infection].
    CHERNOKHVOSTOVA EV
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Jul; 29(7):32-6. PubMed ID: 13582131
    [No Abstract]   [Full Text] [Related]  

  • 12. Etiological agents of bacteraemia and antibiotic susceptibility pattern in Kathmandu Model Hospital.
    Amatya NM; Shrestha B; Lekhak B
    JNMA J Nepal Med Assoc; 2007; 46(167):112-8. PubMed ID: 18274566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The emergence of multidrug resistance to antimicrobial agents for the treatment of typhoid fever.
    Wain J; Kidgell C
    Trans R Soc Trop Med Hyg; 2004 Jul; 98(7):423-30. PubMed ID: 15138079
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infective endocarditis due to Salmonella typhi--a case report.
    Wani T; Kakru DK; Shaheen R; Nazir A; Lone R; Shakeel S; Shah A
    Indian J Pathol Microbiol; 2004 Jan; 47(1):76-7. PubMed ID: 15471142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Sensitivity of S. typhi to antibiotics and sulfonamides (with prolonged action) during chloramphenicol therapy].
    VUCKOVIC-KALENIC K; KOSTIC A; PETROVIC M
    Srp Arh Celok Lek; 1962; 90():733-40. PubMed ID: 13998040
    [No Abstract]   [Full Text] [Related]  

  • 16. [Enhancement of the sensitivity of bacteria of the typhoparatyphoid group to agglutinating antisera by treatment of the germs with lysozyme].
    FERINA F; MELDOLESI MF
    Boll Ist Sieroter Milan; 1960; 39():556-60. PubMed ID: 13698916
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular analysis of multi-drug resistant Salmonella typhi from urban paediatric population of Bangladesh.
    Mamun KZ; Tabassum S; Ashna SM; Hart CA
    Bangladesh Med Res Counc Bull; 2004 Dec; 30(3):81-6. PubMed ID: 16240978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology and risk factors for endemic typhoid fever in Uzbekistan.
    Srikantiah P; Vafokulov S; Luby SP; Ishmail T; Earhart K; Khodjaev N; Jennings G; Crump JA; Mahoney FJ
    Trop Med Int Health; 2007 Jul; 12(7):838-47. PubMed ID: 17596250
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population-based surveillance of typhoid fever in Egypt.
    Srikantiah P; Girgis FY; Luby SP; Jennings G; Wasfy MO; Crump JA; Hoekstra RM; Anwer M; Mahoney FJ
    Am J Trop Med Hyg; 2006 Jan; 74(1):114-9. PubMed ID: 16407354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multidrug resistance in Salmonella enterica serovar typhi isolated from patients with typhoid fever complications in Lagos, Nigeria.
    Akinyemi KO; Smith SI; Oyefolu AO; Coker AO
    Public Health; 2005 Apr; 119(4):321-7. PubMed ID: 15733694
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.